Vitiligo and Thyroid Disease: The Connection and What to Test For

If you have vitiligo, your thyroid deserves attention — not because something is definitely wrong, but because the overlap between the two conditions is significant enough that monitoring is standard of care.

Thyroid disease is the most common comorbidity in vitiligo. Studies consistently find thyroid abnormalities in 15–25% of vitiligo patients, compared to roughly 5% of the general population. The connection is not coincidence — it runs through the same autoimmune mechanisms that drive both conditions.

Why the two conditions overlap

Vitiligo is an autoimmune disease. The immune system develops a misguided attack on melanocytes — the pigment-producing cells in the skin. The thyroid autoimmune conditions — primarily Hashimoto’s thyroiditis and Graves’ disease — involve a similarly misdirected immune attack, in that case on thyroid tissue.

The shared biology is genetic. People with vitiligo carry variants in genes that regulate immune tolerance, particularly in the HLA (human leukocyte antigen) system and in genes like PTPN22, CTLA4, and FOXP3. These same genetic variants increase susceptibility to other autoimmune conditions, including Hashimoto’s and Graves’ disease.

In practical terms: having one autoimmune condition makes you more susceptible to others. Vitiligo and thyroid disease are among the most commonly co-occurring autoimmune pairs.

Hashimoto’s vs Graves’: what is the difference?

Both are autoimmune thyroid conditions, but they work in opposite directions.

Hashimoto’s thyroiditis (also called Hashimoto’s disease or autoimmune hypothyroidism) involves immune attack that gradually destroys thyroid tissue, leading to an underactive thyroid (hypothyroidism). It is more common in women and becomes more prevalent with age. Symptoms include fatigue, weight gain, cold sensitivity, hair loss, depression, and brain fog.

Graves’ disease involves immune stimulation of the thyroid rather than destruction, causing overproduction of thyroid hormones (hyperthyroidism). Symptoms include weight loss, rapid heartbeat, anxiety, heat intolerance, and in some cases, eye changes (Graves’ ophthalmopathy).

Both conditions occur at elevated rates in vitiligo patients. Hashimoto’s is more common overall. Graves’ disease has a particularly noted association with vitiligo.

What tests to request

If you have vitiligo and have not had thyroid testing, or if it has been more than a year since your last check, the following tests are worth requesting from your GP or dermatologist:

TSH (thyroid-stimulating hormone) — the standard first-line thyroid screening test. An elevated TSH suggests hypothyroidism; a suppressed TSH suggests hyperthyroidism. This is the minimum.

Free T4 — measures the active thyroid hormone circulating in the blood. Usually ordered alongside TSH when results are abnormal or borderline.

TPO antibodies (anti-thyroid peroxidase) — the primary marker for Hashimoto’s. Many patients have elevated TPO antibodies for years before TSH becomes abnormal. Identifying this early allows for closer monitoring.

TRAb or TSI (thyroid-stimulating immunoglobulin) — the primary markers for Graves’ disease. Less routinely ordered but worth checking if you have symptoms consistent with hyperthyroidism.

Some dermatologists specialising in vitiligo will order a full thyroid panel as part of initial workup. If yours did not, it is worth asking specifically.

How often to monitor

Recommendations vary, but a reasonable framework:

• At vitiligo diagnosis: baseline TSH and TPO antibodies
• Annually if antibodies are elevated but TSH is normal: because this group has elevated risk of developing clinical hypothyroidism
• As clinically indicated: if symptoms develop, do not wait for the annual check

The thyroid can become abnormal gradually — patients often normalise symptoms as the change is slow. Annual monitoring catches drift before it becomes significant.

Does thyroid disease affect vitiligo?

The relationship is not simply that both conditions co-exist. There is evidence that thyroid dysfunction — particularly untreated hypothyroidism — may worsen immune dysregulation in ways that affect vitiligo activity. Some clinicians report anecdotally that stabilising thyroid function helps stabilise vitiligo spread, though the clinical trial evidence for this specific relationship is limited.

What is clearer: untreated thyroid disease has its own health consequences independent of vitiligo. Treating it is warranted on its own merits, and doing so does not hurt vitiligo outcomes.

If you are on treatment for both conditions, ensure the clinicians managing each know about the other. JAK inhibitors for vitiligo (including Opzelura) have a broad immunomodulatory effect — this is generally not a contraindication to thyroid medication, but it is worth noting.

Other autoimmune conditions to be aware of

Vitiligo increases susceptibility to autoimmune conditions more broadly — not just thyroid disease. Other conditions that occur at elevated rates in vitiligo patients include:

• Alopecia areata — autoimmune hair loss
• Type 1 diabetes — autoimmune destruction of insulin-producing cells
• Addison’s disease (autoimmune adrenal insufficiency) — rare but serious; Addison’s in a vitiligo patient warrants urgent evaluation
• Pernicious anaemia — autoimmune failure to absorb B12
• Rheumatoid arthritis and other inflammatory joint conditions

This does not mean all of these are likely — most vitiligo patients do not develop multiple autoimmune conditions. But it does mean that new symptoms in a vitiligo patient deserve the differential diagnostic work-up that includes autoimmune causes.

The psychological aspects of vitiligo covers the mental health dimension — which is relevant here because untreated hypothyroidism also causes depression and cognitive changes that can compound the emotional burden of vitiligo.

A note on treatment interaction

Patients with active Graves’ disease who are on antithyroid medications (methimazole, propylthiouracil) or who have had radioiodine treatment should mention this when discussing vitiligo treatment options. These treatments affect immune function and thyroid status in ways that may influence both vitiligo activity and the choice of vitiligo treatment.

The vitiligo treatment options comparison gives an overview of the full treatment landscape for reference.

What to do next

If you have vitiligo and have not been tested for thyroid disease:

1. Request a TSH and TPO antibody test from your GP — this is a routine blood test with no special preparation required
2. Ask your dermatologist to note any thyroid history in your vitiligo records
3. If results show elevated antibodies with normal TSH, ask about monitoring frequency
4. If TSH is abnormal, ensure you are referred to or are already seeing an endocrinologist

The connection between vitiligo and thyroid disease is well-established. Testing for it is simple. The cost of missing untreated hypothyroidism or hyperthyroidism is real — and the cost of catching it early is just a blood draw.